Dxome
Latest round
- Series B
Last raised
- Feb 2021
Total raised
- $19M
Investors
- 9
About Dxome
The company has its research and development center and manufacturing plant in Seoul. The company's platform offers clinically actionable insights for personalized treatment through screening panels and detection kits. Its product line includes DxSeq, a cloud-based analysis system that uses Next-Generation Sequencing (NSG); DxReal, which provides a diagnosis of infectious and human diseases through real-time and multiplex PCR processes; and DxTUBE, a blood collection tube that provides prolonged preservation of cfDNA.
Who invested in Dxome
9 investors across 2 rounds
See all investors in Dxome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dxome
Who invested in Dxome?
Dxome has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dxome raised?
Dxome has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Dxome last raise money?
Dxome's most recent round on record is a Series B, in Feb 2021.
What does Dxome do?
The company has its research and development center and manufacturing plant in Seoul.
Where is Dxome headquartered?
Dxome is headquartered in Seongnam, South Korea.
Which VCs invest in companies like Dxome?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare it companies at Dxome's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Dxome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.